ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,897Medicare Part D Prescriptions Filled, Including Refills

Rank: 162 out of 1206

$515K Total Retail Price of All Prescriptions

Rank: 152 out of 1206

444 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 444 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 444 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 9,732 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 575 519 1 2
METOPROLOL SUCCINATE 477 455 2 15
SIMVASTATIN 420 357 3 1
WARFARIN SODIUM 321 311 4 8
OMEPRAZOLE 309 268 5 3
AMLODIPINE BESYLATE 249 231 6 6
FUROSEMIDE 244 227 7 5
LISINOPRIL 231 214 8 4
POTASSIUM CHLORIDE 220 196 9 12
METOPROLOL TARTRATE 185 167 10 9
LISINOPRIL-HYDROCHLOROTHIAZIDE 165 154 11 27
ALENDRONATE SODIUM 160 159 12 19
METFORMIN HCL 158 155 13 10
ATORVASTATIN CALCIUM 157 146 14 13
HYDROCHLOROTHIAZIDE 151 147 15 11
NAMENDA 145 133 16 36
FENOFIBRATE 138 135 17 56
CRESTOR 135 105 18 30
TRAMADOL HCL 132 109 19 17
MELOXICAM 130 104 20 35
GLIMEPIRIDE 129 127 21 34
DONEPEZIL HCL 126 126 22 29
CITALOPRAM HBR 123 122 23 16
ATENOLOL 119 119 24 14
POLYETHYLENE GLYCOL 3350 110 103 25 31
GABAPENTIN 107 106 26 18
SERTRALINE HCL 96 96 27 22
NEXIUM 96 61 27 47
TAMSULOSIN HCL 94 80 29 26
QUINAPRIL HCL 92 70 30 117
MIRTAZAPINE 91 65 31 50
CARBIDOPA-LEVODOPA 82 69 32 70
BISOPROLOL-HYDROCHLOROTHIAZIDE 76 76 33 108
ALLOPURINOL 74 74 34 24
TRIAMTERENE-HCTZ 73 65 35 33
BENAZEPRIL HCL 72 72 36 39
OXYCODONE HCL 69 63 S2 37 107
DIGOXIN 68 60 38 43
TORSEMIDE 67 62 39 144
LANTUS 67 63 39 38
CARBAMAZEPINE 66 54 41 146
PAROXETINE HCL 65 65 42 53
HYDROCODONE-ACETAMINOPHEN 65 49 S3 42 7
CEFUROXIME 64 57 44 157
AMLODIPINE BESYLATE-BENAZEPRIL 63 63 45 76
EXELON 63 63 45 149
ISOSORBIDE MONONITRATE ER 62 62 47 40
QUETIAPINE FUMARATE 58 58 48 79
ZOLPIDEM TARTRATE 56 56 49 25
OLANZAPINE 54 54 50 156
VENLAFAXINE HCL ER 52 47 51 89
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 14, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.